Automotive Sensors Market Size to Reach USD 50.76 Billion By 2032, at 6.2% CAGR | Polaris Market Research
September 23, 2024 08:05 ET
|
Polaris Market Research & Consulting LLP
New York, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Market Outlook: The global automotive sensors market size is predicted to grow from USD 29.47 billion in 2023 to USD 50.76 billion by 2032. It is...
Asendia Partners with Hubbed, introducing innovative Out-of-Home and Returns Cross-Border Solutions to Chinese e-commerce companies
September 23, 2024 08:03 ET
|
Asendia
Asendia partners with Hubbed to offer Chinese e-tailers enhanced cross-border delivery and returns services in the Australian market.
Alliance Trust PLC - Net Asset Value
September 23, 2024 08:02 ET
|
Alliance Trust Plc
ALLIANCE TRUST PLC At the close of business on Friday 20 September 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was - excluding...
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
September 23, 2024 08:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
Arkansas Governor, Local and Community Leaders Congratulate Standard Lithium, Equinor for U.S. Department of Energy Provisional Grant up to US$225 million
September 23, 2024 08:00 ET
|
Standard Lithium
LEWISVILLE, Ark., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium”) (TSXV:SLI) (NYSE American:SLI), a leading near-commercial lithium development company and Equinor, a...
Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress
September 23, 2024 08:00 ET
|
Intra-Cellular Therapies Inc.
Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) Poster...
Monster Digital Adds Significant Digital Production Capacity with the Adoption of 10 Additional Kornit Apollo Systems During 2025
September 23, 2024 08:00 ET
|
Kornit Digital Ltd
On demand manufacturer serves the world’s largest global brands, retailers and e-commerce platformsOperates three locations, nearshore and onshore, running 24/7, promoting new product delivery and...
ORYZON Presents the Final Data From PORTICO, a Global Phase IIb Vafidemstat Trial in Borderline Personality Disorder (BPD), at the European College of Neuropsychopharmacology (ECNP) Congress
September 23, 2024 08:00 ET
|
Oryzon Genomics, S.A.
Strong improvement in State-Trait Anger Expression Inventory 2 (STAXI-2) Trait Anger, a measure of agitation and aggression, at Weeks 8–12 compared to previous top line data; nominal statistical...
Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
September 23, 2024 08:00 ET
|
Theriva Biologics, Inc.
- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept. 23, 2024 (GLOBE...
Hearing Aid Market to Witness 6.30% CAGR by 2031 | SkyQuest Technology
September 23, 2024 08:00 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Hearing Aid Market will attain the value of USD 14.21 Billion by 2031, with a CAGR of 6.30% during the forecast period...